SCHEMBL8993163

SCHEMBL8993163

COc1ccc(C(C)N)c(Cl)c1OC

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
NFKB1 P19838 1/20 0.46
PNMT P11086 1/20 0.46
LMNA P02545 2/20 0.44
ALDH1A1 P00352 1/20 0.44
GLA P06280 1/20 0.44
PDCD1LG2 Q9BQ51 3/20 0.42
CD274 Q9NZQ7 3/20 0.42
AOC3 Q16853 2/20 0.41
TP53 P04637 1/20 0.41
HTT P42858 1/20 0.41
ADRA2A P08913 1/20 0.41
ADRA1A P35348 1/20 0.41
MEN1 O00255 1/20 0.40
MAPK1 P28482 1/20 0.40
BLM P54132 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12061499 0.86 CYP2D6 (0.47) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL19398867 0.86 CYP2D6 (0.47) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL6380570 0.84 AOC3 (0.51) CYP2D6ALDH1A1AOC3ADRA2AADRA1A
SCHEMBL12263333 0.84 CA1 (0.42) AOC3HTTMAPK1
SCHEMBL12075568 0.81 CYP2D6 (0.43) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL27661644 0.81 P2RX7 (0.40) AOC3HTTMAPK1
SCHEMBL19478624 0.78 ALDH1A1 (0.43) LMNAALDH1A1AOC3TP53
SCHEMBL15105529 0.77 ACHE (0.44) ALDH1A1AOC3HTTKMT2A
SCHEMBL23487520 0.77 CYP2D6 (0.60) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL1520565 0.77 ADRA1A (0.54) CYP1A2NFKB1LMNAALDH1A1AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2763539-A1 ANTIBACTERIAL COMPOUNDS Glaxo Group Limited (GB) 2014-08-13 EP disclosed
WO-2013052568-A1 ANTIBACTERIAL COMPOUNDS GLAXO GROUP LIMITED (GB) 2013-04-11 WO disclosed
EP-0476156-B1 SOLID ORAL PREPARATION CONTAINING CATECHOL COMPOUND EISAI CO LTD (JP) 1996-08-07 EP disclosed
US-5292521-A And an organic acid or salt EISAI CO., LTD. (JP) 1994-03-08 US disclosed
EP-0476156-A1 SOLID ORAL PREPARATION CONTAINING CATECHOL COMPOUND Eisai Co., Ltd. (JP) 1992-03-25 EP disclosed